Bernard Jégou

FIL Gestion SASU provides investment advisory services. It offers brokerage and asset management services. The company was founded in 1994 and is headquartered in Paris, France.

The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris.

The neckermann.de GmbH is a mail-order and multi-channel direct marketer firm. Its product offerings include apparel and shoes, leisure products, electronic and household products as well as furniture and home textiles. Neckermann’s specialty business, “Happy Size,” offers a plus size women’s apparel. The company was founded in 1950 and is headquartered in Frankfurt, Germany.

Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector.

Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France.

World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland.

Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.

Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France.

Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland.

Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million.

Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France.

Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.

bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.

French National Institute for Agricultural Research provides research for the betterment in agriculture. It offers research services areas include agroecology, food and nutrition, animal biology, plant biology, biomass, biotechnologies, climate change and economics and social sciences. The company was founded in and is headquartered in Paris, France.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France.

Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics.

Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France.

BioMAdvanced Diagnostics SAS produces molecular diagnostic and biomarker tests related to the immune system. The company is based in Nantes, France. The French company was founded by Nicolas Bouler, Frédéric Pette, Sophie Brouard, Jean-Michel Bouler. Frédéric Pette has been the CEO since incorporation.